Sonographic lesion size of ductal carcinoma in situ as a preoperative predictor for the presence of an invasive focus

Journal of Surgical Oncology

Volumn 98, Issue 1, 2008, Pages 15-20

  Jong, Won Lee ^a   Han, Wonshik ^a   Ko, Eunyoung ^a   Cho, Jihyoung ^a   Kim, Eun Kyu ^a   Jung, So Youn ^a   Cho, Nariya ^a   Woo, Kyung Moon ^a   Park, In Ae ^a   Noh, Dong Young ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Ductal carcinoma in situ; Sonographic lesion size; Underestimation of invasive cancer

Indexed keywords

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; BREAST DUCT; BREAST DUCTAL CARCINOMA IN SITU; BREAST SURGERY; CANCER INVASION; CANCER SIZE; CARCINOMA IN SITU; CHI SQUARE TEST; CORE NEEDLE BIOPSY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MANTEL HAENSZEL TEST; NEEDLE BIOPSY; PALPATION; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BIOPSY, NEEDLE; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PALPATION; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 47149093916     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21077     Document Type: Article

References (25)

1. Liberman L, Feng TL, Dershaw DD, et al.: US-guided core breast biopsy: Use and cost-effectiveness. Radiology 1998;208:717-723.
2. Meyer JE, Smith DN, Lester SC, et al.: Large-core needle biopsy of nonpalpable breast lesions. JAMA 1999;281:1638-1641.
3. Smith DN, Christian R, Meyer JE: Large-core needle biopsy of nonpalpable breast cancers. The impact on subsequent surgical excisions. Arch Surg 1997;132:256-259; discussion 260.
4. Jackman RJ, Burbank F, Parker SH, et al.: Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: Improved reliability with 14-gauge, directional, vacuum-assisted biopsy. Radiology 1997;204:485-488.
5. Darling ML, Smith DN, Lester SC, et al.: Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: Results of surgical excision. Am J Roentgenol 2000;175:1341-1346.
6. Wahedna Y, Evans AJ, Pinder SE, et al.: Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus. Eur J Cancer 2001;37:459-462.
7. Jackman RJ, Burbank F, Parker SH, et al.: Stereotactic breast biopsy of nonpalpable lesions: Determinants of ductal carcinoma in situ underestimation rates. Radiology 2001;218:497-502.
8. King TA, Farr GH Jr, Cederbom GJ, et al.: A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ. Am Surg 2001; 67:907-912.
9. Cox D, Bradley S, England D: The significance of mammotome core biopsy specimens without radiographically identifiable microcalcification and their influence on surgical management - A retrospective review with histological correlation. Breast 2006;15:210-218.
10. Hoorntje LE, Schipper ME, Peeters PH, et al.: The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: Causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy. Ann Surg Oncol 2003; 10:748-753.
11. Yen TW, Hunt KK, Ross MI, et al.: Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: A guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 2005; 200:516-526.
12. Wilkie C, White L, Dupont E, et al.: An update of sentinel lymph node mapping in patients with ductal carcinoma in situ. Am J Surg 2005;190:563-566.
13. Goyal A, Douglas-Jones A, Monypenny I, et al.: Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: Analysis of 587 cases. Breast Cancer Res Treat 2006;98:311-314.
14. Dillon MF, McDermott EW, Quinn CM, et al.: Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only. J Surg Oncol 2006;93:559-563.
15. Rutstein LA, Johnson RR, Poller WR, et al.: Predictors of residual invasive disease after core needle biopsy diagnosis of ductal carcinoma in situ. Breast J 2007;13:251-257.
16. Klauber-DeMore N, Tan LK, Liberman L, et al.: Sentinel lymph node biopsy: Is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion? Ann Surg Oncol 2000;7:636-642.
17. Crystal P, Strano SD, Shcharynski S, Koretz MJ: Using sonography to screen women with mammographically dense breasts. Am J Roentgenol 2003;181:177-182.
18. Kerlikowske K, Grady D, Barclay J, et al.: Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996;276:33-38.
19. del Carmen MG, Halpern EF, Kopans DB, et al.: Mammographic breast density and race. Am J Roentgenol 2007;188:1147-1150.
20. Crystal P, Koretz M, Shcharynsky S, et al.: Accuracy of sonographically guided 14-gauge core-needle biopsy: Results of 715 consecutive breast biopsies with at least two-year follow-up of benign lesions. J Clin Ultrasound 2005;33:47-52.
21. Fajardo LL, Pisano ED, Caudry DJ, et al.: Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: Results of the Radiologic Diagnostic Oncology Group V study. Acad Radiol 2004;11:293-308.
22. Nagashima T, Hashimoto H, Oshida K, et al.: Ultrasound demonstration of mammographically detected microcalcifications in patients with ductal carcinoma in situ of the breast. Breast Cancer 2005;12:216-220.
23. Philpotts LE, Hooley RJ, Lee CH: Comparison of automated versus vacuum-assisted biopsy methods for sonographically guided core biopsy of the breast. Am J Roentgenol 2003;180: 347-351.
24. Cho N, Moon WK, Cha JH, et al.: Sonographically guided core biopsy of the breast: Comparison of 14-gauge automated gun and 11-gauge directional vacuum-assisted biopsy methods. Korean J Radiol 2005;6:102-109.
25. Lyman GH, Giuliano AE, Somerfield MR, et al.: American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-7720.